Advocacy & Practice Updates — Advocacy & Practice
ASRS Member Alert - Endophthalmitis Cases Reported
During the first week of March 2013, a Georgia practice reported 4 cases of endophthalmitis diagnosed within 4 days of an Avastin intraocular injection. The 4 cases presented with a bacterial endophthalmitis with atypical Staphylococcus.
The Avastin was purchased from a local Georgia compounding pharmacy, which has worked with the Georgia Board of Pharmacy and CDC to contact all practices that have recently purchased lots of Avastin.
ASRS is working with the CDC and FDA to investigate all adverse events and report the findings.
ASRS requests that ophthalmologists report any unusual cases of endophthalmitis following an intraocular procedure to Laura Edison, Georgia Department of Public Health, 404-657-6452, email@example.com.
You can also report any adverse events through FDA MedWatch or to the ASRS Therapeutic Surveillance Committee.
Posted March 15, 2013